文献速递MDS 与骨髓增殖性肿瘤

BCR::ABL1阴性骨髓增殖性肿瘤骨髓肿瘤微环境组成与IFN-γ信号及驱动突变的关联

Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations.
PubMed 文献 · Leukemia · 2025-08-05

该研究分析JAK2 V617F突变细胞系、两个MPN队列共265份骨髓活检及50份非肿瘤性骨髓活检,发现JAK2突变MPN存在IFN-γ信号的内在激活,并与肿瘤浸润淋巴细胞增多及预后良好聚类相关;多因素Cox回归显示TILs是最强预后标志物。

要点

  • JAK2突变MPN骨髓中IFN-γ信号通路内在激活,淋巴细胞和单核细胞表达最高。
  • 无监督聚类识别出IFN-γ信号和TILs增高的预后良好聚类,富集JAK2突变、未接受JAK抑制剂治疗的患者。
  • 多因素Cox回归显示肿瘤浸润淋巴细胞是最强预后标志物。

核心结论

  • JAK2突变MPN表现出IFN-γ信号的内在激活,与骨髓肿瘤微环境改变及患者结局相关。

研究设计与样本

  • 研究分析两种人JAK2 V617F突变细胞系、两个MPN队列共265份骨髓活检、50份非肿瘤性骨髓活检及五个公共RNA表达数据集。

主要发现

  • JAK2突变细胞系在细胞上清无IFN-γ时仍显示IFN-γ信号通路激活。
  • JAK2突变样本骨髓活检中IFN-γ信号组分表达异质性增高,淋巴细胞和单核细胞表达最高,伴肿瘤浸润淋巴细胞增多。
  • 无监督聚类在两个患者队列中识别出以IFN-γ信号和TILs增高为特征的预后良好聚类,富集JAK2突变、未接受JAK抑制剂治疗的MPN,主要为原发性血小板增多症和真性红细胞增多症伴轻度骨髓纤维化。
  • 计算机模拟数据证实JAK2突变与IFN-γ信号增高相关。
  • 多因素Cox回归显示TILs是最强预后标志物。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Constitutive JAK/STAT pathway activation is crucial in the pathogenesis of BCR::ABL1-negative myeloproliferative neoplasms (MPN), but has not yet been linked to interferon (IFN)-γ signaling and tumor microenvironment. Human JAK2 V617F-mutated cell lines, 265 bone marrow biopsies (BMB) of two MPN cohorts, and 50 non-neoplastic BMB, revealed an intrinsic activation of IFN-γ signaling, which was confirmed by public RNA expression data. In vitro analysis of JAK2-mutated cell lines showed an activation of IFN-γ signaling pathway in the absence of IFN-γ in the cell supernatants. In addition, a heterogeneous, but increased expression of IFN-γ signaling components was found in BMB of JAK2-mutated samples with the highest expression in lymphocytes and monocytes, accompanied by increased tumor infiltrating lymphocytes (TIL). Unsupervised clustering identified a prognostic favorable cluster in both patient cohorts characterized by augmented IFN-γ signaling and TILs. This cluster was enriched with JAK2-mutated, JAK-inhibition naive MPN, mainly essential thrombocythemia and polycythemia vera with mild bone marrow fibrosis. Moreover, in silico data confirmed the link between JAK2 mutations and increased IFN-γ signaling. Multivariate Cox regression revealed TILs to be the strongest prognostic marker. In conclusion, JAK2-mutated MPN exhibit an intrinsic activation of IFN-γ signaling associated with changes in the BM TME and patients' outcome. Constitutive activation of the Janus kinases and signal transducer and activator of transcription (JAK/STAT) signaling pathway mainly mediated by mutations in the JAK2, CALR and MPL genes in pluripotent hematopoietic stem cells (HSC) is crucial for the pathogenesis of BCR::ABL1-negative myeloproliferative neoplasms (MPN). Despite the activation of JAK/STAT signaling and its influence on the proliferation of malignant cells is well studied in patient samples and JAK2- and CALR-mutated cell systems, there exists limited information about the link between interferon (IFN)-γ signaling and bone marrow (BM) environment alterations. Therefore, two human JAK2 V617F-mutated cell lines, 265 bone marrow biopsies (BMB) of MPN patients, separated in two independent cohorts, both with known clinical parameters, such as driver mutations, treatment and survival, 50 non-neoplastic BMB and five publicly available bulk and single cell RNA expression data sets of MPN samples with known JAK2 or CALR mutation status were analyzed regarding (i) the role of IFN-γ signaling, (ii) its interrelation with the composition of the local BM tumor microenvironment (TME), (iii) the expression of immune response relevant molecules and (iv) their impact on patients' survival. Created in BioRender. Bauer, M. (2025) https://BioRender.com/h133y7w .

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bauer M, Vaxevanis C, Jaekel N, et al. Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations. Leukemia. 2025. PMID: 40764668. doi:10.1038/s41375-025-02706-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。